Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACLX |
---|---|---|
09:32 ET | 2776 | 50.39 |
09:34 ET | 100 | 50.335 |
09:36 ET | 476 | 50.0486 |
09:38 ET | 102 | 50.195 |
09:39 ET | 1032 | 50.31 |
09:41 ET | 600 | 50.71 |
09:43 ET | 500 | 50.86 |
09:45 ET | 412 | 50.695 |
09:48 ET | 1788 | 50.515 |
09:50 ET | 400 | 50.39 |
09:52 ET | 100 | 50.38 |
09:54 ET | 300 | 50.465 |
09:56 ET | 100 | 50.45 |
09:57 ET | 700 | 50.5 |
09:59 ET | 400 | 50.41 |
10:01 ET | 300 | 50.54 |
10:03 ET | 500 | 50.81 |
10:06 ET | 4633 | 51.01 |
10:08 ET | 4004 | 51.36 |
10:10 ET | 2240 | 51.08 |
10:12 ET | 800 | 51.135 |
10:14 ET | 1640 | 51.145 |
10:15 ET | 2302 | 51.085 |
10:17 ET | 200 | 51.105 |
10:19 ET | 724 | 51.205 |
10:21 ET | 800 | 51.4 |
10:26 ET | 600 | 51.485 |
10:28 ET | 100 | 51.315 |
10:30 ET | 1403 | 51.61 |
10:32 ET | 574 | 51.455 |
10:33 ET | 600 | 51.81 |
10:35 ET | 700 | 51.86 |
10:37 ET | 839 | 51.96 |
10:39 ET | 400 | 52.09 |
10:42 ET | 700 | 52.14 |
10:44 ET | 300 | 52.17 |
10:46 ET | 700 | 52.275 |
10:48 ET | 200 | 52.23 |
10:50 ET | 300 | 52.37 |
10:51 ET | 700 | 52.46 |
10:53 ET | 12505 | 52.45 |
10:55 ET | 400 | 52.375 |
10:57 ET | 600 | 52.475 |
11:00 ET | 200 | 52.58 |
11:02 ET | 800 | 52.41 |
11:04 ET | 1736 | 52.51 |
11:06 ET | 2862 | 52.63 |
11:08 ET | 300 | 52.63 |
11:09 ET | 300 | 52.6982 |
11:11 ET | 1000 | 52.6 |
11:13 ET | 500 | 52.61 |
11:18 ET | 2233 | 52.8 |
11:20 ET | 1833 | 52.915 |
11:22 ET | 1319 | 53.02 |
11:24 ET | 600 | 53.005 |
11:26 ET | 1000 | 53.05 |
11:29 ET | 700 | 53.21 |
11:31 ET | 1400 | 53.225 |
11:33 ET | 7480 | 53.275 |
11:36 ET | 4932 | 53.78 |
11:38 ET | 745 | 53.655 |
11:40 ET | 2694 | 53.8225 |
11:42 ET | 400 | 53.74 |
11:44 ET | 400 | 53.81 |
11:45 ET | 3300 | 53.92 |
11:47 ET | 2700 | 54.05 |
11:49 ET | 1317 | 54.205 |
11:51 ET | 600 | 54.18 |
11:54 ET | 700 | 54.09 |
11:56 ET | 300 | 54.2 |
11:58 ET | 400 | 54.27 |
12:00 ET | 6035 | 53.74 |
12:02 ET | 500 | 53.725 |
12:03 ET | 1453 | 53.75 |
12:05 ET | 400 | 53.72 |
12:07 ET | 1485 | 53.56 |
12:09 ET | 3168 | 53.155 |
12:12 ET | 900 | 53.255 |
12:14 ET | 900 | 53.17 |
12:16 ET | 2200 | 53.21 |
12:18 ET | 1100 | 53.4 |
12:20 ET | 100 | 53.35 |
12:21 ET | 100 | 53.36 |
12:23 ET | 700 | 53.38 |
12:25 ET | 800 | 53.39 |
12:27 ET | 1200 | 53.57 |
12:30 ET | 700 | 53.495 |
12:32 ET | 2204 | 53.505 |
12:34 ET | 900 | 53.47 |
12:36 ET | 1372 | 53.45 |
12:38 ET | 600 | 53.47 |
12:39 ET | 300 | 53.53 |
12:41 ET | 200 | 53.54 |
12:43 ET | 1030 | 53.73 |
12:45 ET | 200 | 53.725 |
12:48 ET | 22721 | 53.695 |
12:50 ET | 9028 | 53.68 |
12:52 ET | 708 | 53.6101 |
12:54 ET | 1000 | 53.635 |
12:56 ET | 1744 | 53.67 |
12:57 ET | 200 | 53.74 |
01:01 ET | 300 | 53.74 |
01:03 ET | 2672 | 53.64 |
01:06 ET | 1000 | 53.58 |
01:08 ET | 700 | 53.57 |
01:10 ET | 900 | 53.515 |
01:12 ET | 1300 | 53.55 |
01:14 ET | 500 | 53.555 |
01:15 ET | 800 | 53.545 |
01:17 ET | 500 | 53.545 |
01:19 ET | 300 | 53.565 |
01:21 ET | 200 | 53.56 |
01:24 ET | 1623 | 53.62 |
01:28 ET | 200 | 53.6 |
01:30 ET | 500 | 53.595 |
01:32 ET | 2485 | 53.6 |
01:35 ET | 100 | 53.585 |
01:37 ET | 200 | 53.585 |
01:39 ET | 500 | 53.7 |
01:42 ET | 300 | 53.68 |
01:44 ET | 500 | 53.7 |
01:46 ET | 300 | 53.7 |
01:50 ET | 700 | 53.83 |
01:51 ET | 168 | 53.825 |
01:53 ET | 1478 | 53.69 |
01:55 ET | 843 | 53.69 |
02:02 ET | 300 | 53.74 |
02:04 ET | 300 | 53.71 |
02:06 ET | 200 | 53.695 |
02:08 ET | 600 | 53.69 |
02:09 ET | 500 | 53.7 |
02:11 ET | 1300 | 53.67 |
02:13 ET | 700 | 53.67 |
02:15 ET | 1550 | 53.8 |
02:18 ET | 1000 | 53.82 |
02:20 ET | 366 | 53.8328 |
02:22 ET | 1079 | 53.87 |
02:24 ET | 566 | 53.92 |
02:26 ET | 1704 | 53.995 |
02:27 ET | 350 | 53.9 |
02:29 ET | 729 | 53.915 |
02:31 ET | 400 | 53.895 |
02:33 ET | 1030 | 53.96 |
02:36 ET | 100 | 53.95 |
02:38 ET | 804 | 54.03 |
02:40 ET | 200 | 54.02 |
02:42 ET | 100 | 54.07 |
02:44 ET | 200 | 54.18 |
02:45 ET | 804 | 54.18 |
02:47 ET | 2223 | 54.21 |
02:49 ET | 300 | 54.29 |
02:51 ET | 913 | 54.35 |
02:54 ET | 800 | 54.3 |
02:56 ET | 100 | 54.3 |
02:58 ET | 400 | 54.27 |
03:00 ET | 116 | 54.26 |
03:02 ET | 2360 | 54.095 |
03:03 ET | 700 | 54.15 |
03:05 ET | 500 | 54.18 |
03:07 ET | 415 | 54.185 |
03:09 ET | 400 | 54.19 |
03:12 ET | 2575 | 53.9575 |
03:14 ET | 772 | 54.01 |
03:16 ET | 200 | 54.13 |
03:18 ET | 225 | 54.135 |
03:20 ET | 100 | 54.13 |
03:21 ET | 6902 | 54.16 |
03:23 ET | 300 | 54.17 |
03:25 ET | 1052 | 54.284 |
03:27 ET | 1100 | 54.225 |
03:30 ET | 200 | 54.25 |
03:32 ET | 200 | 54.235 |
03:34 ET | 1290 | 54.19 |
03:36 ET | 5662 | 54.12 |
03:38 ET | 1200 | 54.11 |
03:39 ET | 331 | 54.13 |
03:41 ET | 5019 | 54 |
03:43 ET | 2319 | 53.93 |
03:45 ET | 1702 | 53.88 |
03:48 ET | 400 | 53.87 |
03:50 ET | 1200 | 53.87 |
03:52 ET | 3385 | 53.83 |
03:54 ET | 2354 | 53.84 |
03:56 ET | 2764 | 53.87 |
03:57 ET | 5351 | 54 |
03:59 ET | 107795 | 54.13 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcellx Inc | 2.7B | -52.1x | --- |
Rhythm Pharmaceuticals Inc | 2.4B | -8.9x | --- |
Agios Pharmaceuticals Inc | 2.7B | -7.5x | --- |
Geron Corp | 2.7B | -14.6x | --- |
IDEAYA Biosciences Inc | 2.9B | -19.2x | --- |
MoonLake Immunotherapeutics | 2.7B | -55.9x | --- |
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -52.1x |
Price/Sales (TTM) | 20.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.